The Xcell™ portfolio from NewBiologix is a comprehensive suite of advanced technologies designed to power next generation gene and cell therapies. Designed with Swiss-precision and flexibility, Xcell™ offers a robust foundation for developing and manufacturing reliable gene therapies. Our technologies help companies efficiently move from discovery to commercialization, ensuring better patient outcomes through safer, faster and more effective therapies.
Our HEK293-based cell lines and advanced platform services are tailored to tackle complex gene therapy production challenges such as low yields and toxicity associated with replication or capsid genes. Using our suite of advanced technologies, our partners benefit from faster timelines and seamless scalability from research to commercialization.
